AAT Bioquest
Private Company
Total funding raised: $40M
Overview
AAT Bioquest is a privately held, revenue-generating life sciences tools and diagnostics company founded in 1998 and headquartered in Pleasanton, California. It has established itself as a specialized provider of innovative photometric detection reagents and assay kits, leveraging expertise in chemistry and biology to serve a global customer base from academic institutions to large pharmaceutical companies. The company's business model is built on catalog product sales and custom services, with a strong emphasis on scientific collaboration and technical support. Its growth is driven by a consistent pipeline of novel reagents and a global distribution network.
Technology Platform
Specialized platform in photometric detection technologies, including fluorescence, luminescence, and colorimetric assays. Core expertise encompasses fluorescent dye chemistry, bioconjugation reagents, functional assay kits, and signal amplification systems for life science research and diagnostic development.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
AAT Bioquest competes in the fragmented life sciences reagents market against giants like Thermo Fisher Scientific and Merck KGaA, as well as numerous specialized reagent companies. Its differentiation is based on deep expertise in photometric detection, a focused portfolio of high-performance probes and kits, and strong technical customer support.